Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Tracy Frech, MD,MS
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Disclosure information not submitted.
Monique Hinchcliff, MD;MS
Yale School of Medicine
Westport, Connecticut, United States
Disclosure(s): AbbVie/Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boehringer-Ingelheim: Grant/Research Support (Ongoing)
This state-of-the-art lecture will feature talks from two individuals who are leading experts in precision medicine research in systemic sclerosis (SSc). Both will present data from large cohorts (EUSTAR, CONQUER) and discuss novel ways for defining molecular phenotypes and measuring treatment response. At the conclusion of this lecture, the audience will gain an improved understanding of the latest research in SSc from real-word data representative of US and European cohorts and understand how response biomarkers can be applied in clinical practice to make treatment decisions.
Speaker: Francesco Del Galdo, MD,PhD – University of Leeds
Speaker: Elizabeth Volkmann, MD,MS – University of California, Los Angeles